LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 60

Search options

  1. Article ; Online: "Lyn"king Emphysema and Cancer Development: Insights from Src Family Kinase Gain-of-Function Models.

    Suresh, Karthik

    American journal of respiratory cell and molecular biology

    2023  Volume 69, Issue 1, Page(s) 8–9

    MeSH term(s) Humans ; src-Family Kinases/genetics ; src-Family Kinases/metabolism ; Gain of Function Mutation ; Protein-Tyrosine Kinases/metabolism ; Phosphorylation ; Lung Neoplasms/genetics ; Emphysema
    Chemical Substances src-Family Kinases (EC 2.7.10.2) ; Protein-Tyrosine Kinases (EC 2.7.10.1)
    Language English
    Publishing date 2023-04-19
    Publishing country United States
    Document type Editorial ; Research Support, N.I.H., Extramural ; Comment
    ZDB-ID 1025960-0
    ISSN 1535-4989 ; 1044-1549
    ISSN (online) 1535-4989
    ISSN 1044-1549
    DOI 10.1165/rcmb.2023-0122ED
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Sex as a biologic variable: evidence from isolated lung endothelial cells.

    Suresh, Karthik

    American journal of physiology. Lung cellular and molecular physiology

    2022  Volume 323, Issue 5, Page(s) L646–L647

    MeSH term(s) Humans ; Endothelial Cells ; Lung ; Hypertension, Pulmonary ; Biological Products
    Chemical Substances Biological Products
    Language English
    Publishing date 2022-11-09
    Publishing country United States
    Document type Letter ; Comment
    ZDB-ID 1013184-x
    ISSN 1522-1504 ; 1040-0605
    ISSN (online) 1522-1504
    ISSN 1040-0605
    DOI 10.1152/ajplung.00242.2022
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Pulmonary toxicity of immune checkpoint immunotherapy.

    Ghanbar, Mohammad I / Suresh, Karthik

    The Journal of clinical investigation

    2024  Volume 134, Issue 2

    Abstract: Cancer remains a leading cause of mortality on a global scale. Lung cancer, specifically non-small cell lung cancer (NSCLC), is a prominent contributor to this burden. The management of NSCLC has advanced substantially in recent years, with ... ...

    Abstract Cancer remains a leading cause of mortality on a global scale. Lung cancer, specifically non-small cell lung cancer (NSCLC), is a prominent contributor to this burden. The management of NSCLC has advanced substantially in recent years, with immunotherapeutic agents, such as immune checkpoint inhibitors (ICIs), leading to improved patient outcomes. Although generally well tolerated, the administration of ICIs can result in unique side effects known as immune-related adverse events (irAEs). The occurrence of irAEs involving the lungs, specifically checkpoint inhibitor pneumonitis (CIP), can have a profound effect on both future therapy options and overall survival. Despite CIP being one of the more common serious irAEs, limited treatment options are currently available, in part due to a lack of understanding of the underlying mechanisms involved in its development. In this Review, we aim to provide an overview of the epidemiology and clinical characteristics of CIP, followed by an examination of the emerging literature on the pathobiology of this condition.
    MeSH term(s) Humans ; Carcinoma, Non-Small-Cell Lung/drug therapy ; Lung Neoplasms/drug therapy ; Antineoplastic Agents, Immunological/adverse effects ; Pneumonia ; Immunotherapy/adverse effects ; Drug-Related Side Effects and Adverse Reactions
    Chemical Substances Antineoplastic Agents, Immunological
    Language English
    Publishing date 2024-01-16
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 3067-3
    ISSN 1558-8238 ; 0021-9738
    ISSN (online) 1558-8238
    ISSN 0021-9738
    DOI 10.1172/JCI170503
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: mtROS-Induced TRPV4 Activation in Traumatic Brain Injury.

    Suresh, Karthik

    Journal of neurotrauma

    2018  Volume 36, Issue 4, Page(s) 639

    MeSH term(s) Brain Injuries, Traumatic ; Cerebral Arteries ; Constriction ; Humans ; Hydrogen Peroxide ; Mitochondria ; TRPV Cation Channels
    Chemical Substances TRPV Cation Channels ; TRPV4 protein, human ; Hydrogen Peroxide (BBX060AN9V)
    Language English
    Publishing date 2018-07-05
    Publishing country United States
    Document type Journal Article ; Comment
    ZDB-ID 645092-1
    ISSN 1557-9042 ; 0897-7151
    ISSN (online) 1557-9042
    ISSN 0897-7151
    DOI 10.1089/neu.2018.5847
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Post hoc survival analyses using RNAseq data: handle with care.

    Suresh, Karthik / Psoter, Kevin J

    American journal of physiology. Lung cellular and molecular physiology

    2022  Volume 324, Issue 1, Page(s) L1–L4

    Abstract: With the advent of next-generation sequencing technologies, there has been a dramatic increase in the availability of paired clinical and transcriptomic data in a variety of disease states. For basic science researchers, this has provided a valuable ... ...

    Abstract With the advent of next-generation sequencing technologies, there has been a dramatic increase in the availability of paired clinical and transcriptomic data in a variety of disease states. For basic science researchers, this has provided a valuable opportunity for querying the impact of the transcript levels of a gene on disease survival in humans. However, there are a multitude of methodological and technical considerations to evaluate before embarking on these analyses. Herein, we provide a brief description of statistical considerations involved in these analyses, geared toward basic scientists who may not necessarily routinely use such statistical models as part of their studies.
    MeSH term(s) Humans ; Gene Expression Profiling ; Transcriptome/genetics ; High-Throughput Nucleotide Sequencing
    Language English
    Publishing date 2022-11-21
    Publishing country United States
    Document type Editorial ; Research Support, N.I.H., Extramural
    ZDB-ID 1013184-x
    ISSN 1522-1504 ; 1040-0605
    ISSN (online) 1522-1504
    ISSN 1040-0605
    DOI 10.1152/ajplung.00037.2022
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Pulmonary toxicity of systemic lung cancer therapy.

    Long, Kathryn / Suresh, Karthik

    Respirology (Carlton, Vic.)

    2020  Volume 25 Suppl 2, Page(s) 72–79

    Abstract: Lung cancer is the leading cause of cancer-related deaths worldwide. As new therapies are developed, it is important to understand the pulmonary toxicities associated with systemic lung cancer therapies. Cytotoxic chemotherapy regimens for NSCLC often ... ...

    Abstract Lung cancer is the leading cause of cancer-related deaths worldwide. As new therapies are developed, it is important to understand the pulmonary toxicities associated with systemic lung cancer therapies. Cytotoxic chemotherapy regimens for NSCLC often include taxanes. Pulmonary toxicity from taxanes presents as an ILD-type reaction characterized by increasing dyspnoea, dry cough, fever and bilateral pulmonary interstitial infiltrates. The incidence of taxane-induced pneumonitis is rare, and many patients respond to steroid therapy; however, fatal cases have been reported. Patients with NSCLC are routinely tested for the presence of tumour oncogenes to determine their candidacy for targeted therapies, such as TKI. EGFR-TKI can cause pneumonitis characterized by progressive dyspnoea and hypoxia. EGFR-TKI-associated ILD rarely presents as an AIP with rapidly progressive respiratory failure and high mortality rates. The most recent development in lung cancer therapy has been the discovery of immune checkpoint inhibitor (ICI). ICI pneumonitis has been increasingly recognized as a common complication of ICI therapy, with reported incidence as high as 19% in some clinical settings. Early-grade ICI pneumonitis may be asymptomatic; however, high-grade ICI pneumonitis can result in progressive dyspnoea, hypoxia and respiratory failure. ICI pneumonitis is unique in that only half of the patients will improve with steroid treatment, and mortality rates are high. As treatment of NSCLC evolves, providers must be able to recognize and respond to the development of drug-induced pulmonary toxicities.
    MeSH term(s) Antineoplastic Agents/adverse effects ; Carcinoma, Non-Small-Cell Lung/drug therapy ; Carcinoma, Non-Small-Cell Lung/pathology ; Dyspnea/chemically induced ; Humans ; Hypoxia/chemically induced ; Immune Checkpoint Inhibitors/adverse effects ; Lung Neoplasms/drug therapy ; Lung Neoplasms/pathology ; Molecular Targeted Therapy ; Pneumonia/chemically induced ; Protein Kinase Inhibitors/adverse effects ; Taxoids/adverse effects
    Chemical Substances Antineoplastic Agents ; Immune Checkpoint Inhibitors ; Protein Kinase Inhibitors ; Taxoids
    Language English
    Publishing date 2020-07-29
    Publishing country Australia
    Document type Journal Article ; Review
    ZDB-ID 1435849-9
    ISSN 1440-1843 ; 1323-7799
    ISSN (online) 1440-1843
    ISSN 1323-7799
    DOI 10.1111/resp.13915
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: A Multidisciplinary Approach for Patients with Preexisting Lung Diseases and Immune Checkpoint Inhibitor Toxicities.

    Naidoo, Jarushka / Suresh, Karthik

    The oncologist

    2020  Volume 25, Issue 11, Page(s) e1589–e1592

    MeSH term(s) B7-H1 Antigen ; Humans ; Immune Checkpoint Inhibitors ; Immunotherapy ; Lung Diseases/chemically induced ; Programmed Cell Death 1 Receptor
    Chemical Substances B7-H1 Antigen ; Immune Checkpoint Inhibitors ; Programmed Cell Death 1 Receptor
    Language English
    Publishing date 2020-09-14
    Publishing country England
    Document type Journal Article
    ZDB-ID 1409038-7
    ISSN 1549-490X ; 1083-7159
    ISSN (online) 1549-490X
    ISSN 1083-7159
    DOI 10.1634/theoncologist.2020-0266
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: A novel interaction between aquaporin 1 and caspase-3 in pulmonary arterial smooth muscle cells.

    Niedermeyer, Shannon / Yun, Xin / Trujillo, Marielena / Jiang, Haiyang / Andrade, Manuella R / Kolb, Todd M / Suresh, Karthik / Damarla, Mahendra / Shimoda, Larissa A

    American journal of physiology. Lung cellular and molecular physiology

    2024  Volume 326, Issue 5, Page(s) L638–L645

    Abstract: Pulmonary hypertension (PH) is a condition in which remodeling of the pulmonary vasculature leads to hypertrophy of the muscular vascular wall and extension of muscle into nonmuscular arteries. These pathological changes are predominantly due to the ... ...

    Abstract Pulmonary hypertension (PH) is a condition in which remodeling of the pulmonary vasculature leads to hypertrophy of the muscular vascular wall and extension of muscle into nonmuscular arteries. These pathological changes are predominantly due to the abnormal proliferation and migration of pulmonary arterial smooth muscle cells (PASMCs), enhanced cellular functions that have been linked to increases in the cell membrane protein aquaporin 1 (AQP1). However, the mechanisms underlying the increased AQP1 abundance have not been fully elucidated. Here we present data that establishes a novel interaction between AQP1 and the proteolytic enzyme caspase-3. In silico analysis of the AQP1 protein reveals two caspase-3 cleavage sites on its C-terminal tail, proximal to known ubiquitin sites. Using biotin proximity ligase techniques, we establish that AQP1 and caspase-3 interact in both human embryonic kidney (HEK) 293A cells and rat PASMCs. Furthermore, we demonstrate that AQP1 levels increase and decrease with enhanced caspase-3 activity and inhibition, respectively. Ultimately, further work characterizing this interaction could provide the foundation for novel PH therapeutics.
    MeSH term(s) Aquaporin 1/metabolism ; Aquaporin 1/genetics ; Humans ; Animals ; Myocytes, Smooth Muscle/metabolism ; Myocytes, Smooth Muscle/pathology ; Pulmonary Artery/metabolism ; Pulmonary Artery/pathology ; Caspase 3/metabolism ; Rats ; HEK293 Cells ; Muscle, Smooth, Vascular/metabolism ; Muscle, Smooth, Vascular/pathology ; Male ; Hypertension, Pulmonary/metabolism ; Hypertension, Pulmonary/pathology ; Rats, Sprague-Dawley ; Cell Proliferation
    Chemical Substances Aquaporin 1 (146410-94-8) ; Caspase 3 (EC 3.4.22.-) ; Aqp1 protein, rat
    Language English
    Publishing date 2024-02-20
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
    ZDB-ID 1013184-x
    ISSN 1522-1504 ; 1040-0605
    ISSN (online) 1522-1504
    ISSN 1040-0605
    DOI 10.1152/ajplung.00017.2024
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Lower Survival in Patients Who Develop Pneumonitis Following Immunotherapy for Lung Cancer.

    Suresh, Karthik / Naidoo, Jarushka

    Clinical lung cancer

    2019  Volume 21, Issue 3, Page(s) e169–e170

    MeSH term(s) Carcinoma, Non-Small-Cell Lung ; Humans ; Immunotherapy/adverse effects ; Lung Neoplasms/therapy ; Pneumonia/etiology ; Prognosis ; Risk Factors
    Language English
    Publishing date 2019-11-06
    Publishing country United States
    Document type Letter ; Comment
    ZDB-ID 2145146-1
    ISSN 1938-0690 ; 1525-7304
    ISSN (online) 1938-0690
    ISSN 1525-7304
    DOI 10.1016/j.cllc.2019.10.009
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Immune Checkpoint Inhibitor Use in Sepsis: Monitoring Immune Checkpoint Inhibitor Toxicity.

    Suresh, Karthik / D'Alessio, Franco

    Critical care medicine

    2019  Volume 47, Issue 9, Page(s) e788

    MeSH term(s) Antibodies, Monoclonal ; Antibodies, Monoclonal, Humanized ; B7-H1 Antigen ; Humans ; Programmed Cell Death 1 Receptor ; Sepsis
    Chemical Substances Antibodies, Monoclonal ; Antibodies, Monoclonal, Humanized ; B7-H1 Antigen ; Programmed Cell Death 1 Receptor ; BMS-936559 (TLZ6R6973Z)
    Language English
    Publishing date 2019-08-22
    Publishing country United States
    Document type Letter ; Comment
    ZDB-ID 197890-1
    ISSN 1530-0293 ; 0090-3493
    ISSN (online) 1530-0293
    ISSN 0090-3493
    DOI 10.1097/CCM.0000000000003813
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top